SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-23-000612
Filing Date
2023-04-27
Accepted
2023-04-27 08:30:37
Documents
1
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 e618550_3-rudick.html 3  
1 e618550_3-rudick.xml 3 1503
  Complete submission text file 0001193805-23-000612.txt   2957
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1200 AVENUE OF THE AMERICAS, SUITE 200 NEW YORK NY 10036
Business Address
Rudick Richard Alan (Reporting) CIK: 0001975263 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36201 | Film No.: 23852100